Document is current
Any future updates will be listed below
-
Authors
Stecklein, Shane R. http://orcid.org/0000-0001-8322-5886
Kimler, Bruce F. http://orcid.org/0000-0001-7021-6964
Yoder, Rachel
Schwensen, Kelsey
Staley, Joshua M. http://orcid.org/0000-0001-9273-0286
Khan, Qamar J. http://orcid.org/0000-0002-6287-020X
O’Dea, Anne P.
Nye, Lauren E.
Elia, Manana
Heldstab, Jaimie
Home, Trisha
Hyter, Stephen
Isakova, Kamilla
Pathak, Harsh B.
Godwin, Andrew K. http://orcid.org/0000-0002-3987-9580
Sharma, Priyanka http://orcid.org/0000-0001-8592-2239
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30CA168524, P30CA168524)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (KL2TR002367)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (P20GM130423, P20GM130423)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
- License Information
-
More Information
Article History
Received: 9 September 2022
Accepted: 7 February 2023
First Online: 6 March 2023
Competing interests
: A.P.O.: Consulting honoraria from Pfizer, Puma Biotechnology, Novartis, Daiichi Sankyo, Astra Zeneca, and Seattle Genetics; A.K.G.: Co-founder of Sinochips Diagnostics, serves as a scientific advisory board member to Biovica, Clara Biotech, and Sinochips Diagnostics, and receives research funding from Predicine and VITRAC Therapeutics; P.S.: Research funding from Novartis, Merck, Gilead, and BMS; serves as a consultant/advisor to AstraZeneca, Novartis, Merck, GSK, Pfizer, Sanofi, and Genzyme; and receives royalties from UpToDate. The remaining authors declare no competing interests.
